Metrowest Cancer Center is a clinical research site located in Framingham, Massachusetts, United States 01702.
Crixeo Health Trust Score: 51/100 (POOR). This profile has not yet been claimed by the site owner.
Metrowest Cancer Center has participated in 1 clinical trials.
Therapeutic areas: Non-Small Cell Lung Cancer.
Sponsors: Genentech, Inc..
Trust Score: 51/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
Metrowest Cancer Center has a Crixeo Trust Score of 51/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Metrowest Cancer Center has 1 clinical trials on record. Their work covers Non-Small Cell Lung Cancer.
Metrowest Cancer Center has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.